Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based...
Day: April 16, 2021
Leveljump Announces Fiscal 2020 Earnings and Results
Toronto, Ontario--(Newsfile Corp. - April 16, 2021) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), a Canadian leader...
Alkame Holdings, Inc. Announces Corporate Update
LAS VEGAS, NV / ACCESSWIRE / April 16, 2021 / Alkame Holdings, Inc. (OTC PINK:ALKM), is pleased to provide an...
COVID-19 Testing: Grapefruit Testing Bringing Best-In-Class Tests to Schools & Organizations
NEW YORK, NY / ACCESSWIRE / April 16, 2021 / Many players have come into the COVID-19 return-to-work space. Large...
Synertech Medical Launches Single-Use Sterile Dural Repair Kit in the US to Improve Operating Room Efficiency
CHESHIRE, UK / ACCESSWIRE / April 16, 2021 / Synertech, a medical device company aiming to provide simple surgical solutions,...
Vistin Pharma ASA: Invitation to Q1 2021 conference call
Oslo, Norway, 16 April 2021 Vistin Pharma ASA will release its first quarter 2021 results on Friday 23rd of April 2021....
LIDDS Annual Report 2020
UPPSALA, SWEDEN – LIDDS publishes Annual Report for 2020 The Annual Report is attached to this press release and alos...
Cerner to Release First Quarter 2021 Earnings Results May 5
KANSAS CITY, Mo., April 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its first...
Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021
-- Adverum to host webcast with key opinion leaders on Sunday, May 2, 2021 at 7:00 AM PT -- REDWOOD CITY, Calif.,...
Zogenix Presents New Data from a Study Highlighting the Impact of Treatment with FINTEPLA® (Fenfluramine) Oral Solution on Dravet Syndrome Patients, Caregivers, and Families at Virtual AAN 2021
Seizure Related Benefits noted by caregivers included reduction in frequency, fewer triggers causing seizures, and shorter recovery time when seizure...
Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021
TEMPLE CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a...
Aleafia Health to Announce 2021 First Quarter Results
TORONTO, April 16, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) will...
Immutep Receives A$1,155,055 R&D Tax Incentive
SYDNEY, AUSTRALIA, April 16, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased...
TG Therapeutics Announces Positive Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at American Academy of Neurology 73rd Annual Meeting
Ublituximab demonstrated superiority versus teriflunomide in reducing annualized relapse rates and MRI brain lesions Ublituximab was generally well tolerated, with...
Robert J. Folkes Joins PetVivo Holdings, Inc. as Chief Financial Officer
PETVIVO HOLDINGS, INC Robert J. Folkes MINNEAPOLIS, MN, US, April 16, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV)...
New Data at AAN 2021 from Across Biogen’s MS Portfolio Demonstrate Positive Impact of Treatment on People Living with Relapsing Multiple Sclerosis
New findings from MS PATHS show that treatment with TYSABRI® (natalizumab) can lead to meaningful improvements in mental and social health compared...
CareDx to Present at UNOS Transplant Management Forum
Company to showcase its latest integrated solutions for improving care across the whole transplant journeySOUTH SAN FRANCISCO, Calif., April 16,...
Tauriga Sciences Inc. Showcases Blister Pack Design for its Evergreen Mint Flavor, Delta 8 THC Infused, Version of Tauri-Gum
Tauriga 04-16-2021 Image of Delta 8 THC Infused Tauri-Gum™ Blister Pack NEW YORK, NY, April 16, 2021 (GLOBE NEWSWIRE) --...
Relay Therapeutics Extends Leadership in Integrating Computational and Experimental Approaches to Create Precision Medicines by Acquiring ZebiAI
Relay Therapeutics’ leadership in this new breed of biotech positions the company as a strategic partner of choice for emerging technologies...
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their...